Cargando…
A phenotypic high-content, high-throughput screen identifies inhibitors of NLRP3 inflammasome activation
Inhibition of the NACHT, LRR and PYD domains-containing protein 3 (NLRP3) inflammasome has recently emerged as a promising therapeutic target for several inflammatory diseases. After priming and activation by inflammation triggers, NLRP3 forms a complex with apoptosis-associated speck-like protein c...
Autores principales: | Nizami, Sohaib, Millar, Val, Arunasalam, Kanisa, Zarganes-Tzitzikas, Tryfon, Brough, David, Tresadern, Gary, Brennan, Paul E., Davis, John B., Ebner, Daniel, Di Daniel, Elena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8319173/ https://www.ncbi.nlm.nih.gov/pubmed/34321581 http://dx.doi.org/10.1038/s41598-021-94850-w |
Ejemplares similares
-
Author Correction: A phenotypic high-content, high-throughput screen identifies inhibitors of NLRP3 inflammasome activation
por: Nizami, Sohaib, et al.
Publicado: (2021) -
Inhibition of the NLRP3 inflammasome by HSP90 inhibitors
por: Nizami, Sohaib, et al.
Publicado: (2020) -
Nanoscale, automated, high throughput synthesis and screening for the accelerated discovery of protein modifiers
por: Gao, Kai, et al.
Publicado: (2021) -
Atorvastatin (Lipitor) by MCR
por: Zarganes-Tzitzikas, Tryfon, et al.
Publicado: (2019) -
Synthesis of Highly Substituted Imidazole Uracil Containing
Molecules via Ugi-4CR and Passerini-3CR
por: Madhavachary, Rudrakshula, et al.
Publicado: (2018)